Free Anti-Infliximab

Free Anti-Infliximab
Detecting the development of Anti-drug antibodies (ADAs) against Infliximab in patients being treated with Infliximab for chronic autoimmune and inflammatory conditions

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Infliximab can detect the presence of anti-drug antibodies against Infliximab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 12 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

About Using Reagent

• Sample Types Whole blood, Serum
• Reaction Time 12 mins
  
• Detection Range 4-250 AU/mL
  
• Indication Semi-quantitative determination of free antibodies to infliximab in human whole blood/serum
  

Click